Free Trial

Cogent Biosciences (COGT) Insider Trading & Ownership

Cogent Biosciences logo
$8.19 -0.07 (-0.85%)
(As of 12/17/2024 05:30 PM ET)

Cogent Biosciences (NASDAQ:COGT) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
5.92%
Number Of
Insiders Buying
(Last 3 Years)
1
Amount Of
Insider Buying
(Last 3 Years)
$19.50 M
Number Of
Insiders Selling
(Last 3 Years)
0
Get COGT Insider Trade Alerts

Want to know when executives and insiders are buying or selling Cogent Biosciences stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

COGT Insider Buying and Selling by Quarter

Cogent Biosciences Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
6/9/2023Fairmount Funds Management LlcMajor ShareholderBuy800,000$12.00$9,600,000.00  
6/16/2022Fairmount Funds Management LlcMajor ShareholderBuy1,200,000$8.25$9,900,000.00  
(Data available from 1/1/2013 forward)

COGT Insider Trading Activity - Frequently Asked Questions

The list of insiders at Cogent Biosciences includes Fairmount Funds Management Llc. Learn more on insiders at COGT.

5.92% of Cogent Biosciences stock is owned by insiders. Learn more on COGT's insider holdings.

The following insider purchased COGT shares in the last 24 months: Fairmount Funds Management Llc ($9,600,000.00).

Insiders have purchased a total of 800,000 COGT shares in the last 24 months for a total of $9,600,000.00 bought.

Cogent Biosciences Key Executives

  • Mr. Andrew R. Robbins M.B.A. (Age 48)
    President, CEO & Director
    Compensation: $1.06M
  • Dr. John Edward Robinson Ph.D. (Age 49)
    Chief Scientific Officer
    Compensation: $749.89k
  • Dr. Jessica Sachs M.D. (Age 49)
    Chief Medical Officer
    Compensation: $773.92k
  • Mr. John L. Green C.A.Mr. John L. Green C.A. (Age 44)
    CPA, CFO & Principal Accounting Officer
    Compensation: $763.99k
  • Mr. Brad Barnett
    Chief Technology Officer
  • Christi Waarich
    Senior Director of Investor Relations
  • Mr. Evan D. Kearns J.D. (Age 44)
    Chief Legal Officer & Corporate Secretary
  • Ms. Erin Schellhammer
    Chief People Officer
  • Mr. Dana R. Martin Pharm.D.
    Senior VP of Medical Affairs & Chief Patient Officer
  • Brad Fell
    Senior Vice President of Chemistry


This page (NASDAQ:COGT) was last updated on 12/18/2024 by MarketBeat.com Staff
From Our Partners